Article
04/26/2022
menu
Nevro is a medical device company and creator of HF10®,
an innovative, evidence-based treatment for chronic pain.
The company, based in Redwood City, California has a simple goal of helping more patients suffering from chronic pain achieve lasting relief.
While traditional spinal cord stimulation (SCS) has been around for over 30 years, HF10 created a disruption by offering a next-generation approach that provides patients with substantially better long-term outcomes.
HF10 has been available in Europe and Australia since 2011 and received FDA approval in the United States in 2015. Uniquely, the FDA designated HF10 as superior to traditional SCS for the treatment of back and leg pain.
Worldwide, tens of thousands of patients are enjoying more freedom and improvement in their daily lives with HF10.
Article
04/26/2022
Article
03/01/2021
Article
03/01/2021
(Select all areas where you experience pain)
No Pain
0 1 2 3 4 5 6 7 8 9 10Worst Pain Imaginable
No Pain
Worst Pain Imaginable
(Select all options you've tried)
At this time, it looks like you might not be an appropriate candidate for HFX. The next best step is to talk with the physician who is treating your pain about your treatment options.
To learn more about who this treatment option is right for, visit our learn center:
Learn MoreYou may not be ready for HFX now, however if your pain lasts longer than 6 months, please come back to see if you qualify.
Learn MoreYou may not be ready for HFX now, however if your pain severity increases, please come back to see if you qualify.
Learn MoreBy clicking ‘I agree & submit’, you agree to receive automated SMS texts from Nevro at the mobile number provided and agree to Nevro’s Text Message Terms of Service & Privacy Notice. Message and data rates may apply. Message frequency varies. You can opt-out at any time by texting STOP to 35788. You can also text HELP to 35788 for HELP. You also agree to email and phone communications from Nevro and opportunities to participate in Nevro led research panels and quantitative surveys. You understand that you can choose to participate or decline to participate in any marketing panel. You understand that you can opt-out of further advertising and/or marketing research communications from Nevro by clicking unsubscribe in the email or providing a detailed request to opt-out@nevro.com.
All information will be used in accordance with Nevro’s Privacy Notice.
Your results and discussion guide will be on their way shortly.
Please find a copy at the email address provided.
We did not update your responses. Your results and discussion guide will be based on your previous responses. Please find a copy at the email address provided.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on medical devices and other products or uses of those products that are not approved in other countries or regions.
Do you wish to continue?
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on medical devices and other products or uses of those products that are not approved in your country or region.